(FBIZ) First Business Financial - Overview
Stock: Commercial Lending, Treasury Management, Wealth Management, Deposit Accounts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.35% |
| Yield on Cost 5y | 7.66% |
| Yield CAGR 5y | 12.66% |
| Payout Consistency | 98.8% |
| Payout Ratio | 19.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.1% |
| Relative Tail Risk | -12.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.29 |
| Alpha | -1.06 |
| Character TTM | |
|---|---|
| Beta | 0.757 |
| Beta Downside | 0.750 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.29% |
| CAGR/Max DD | 0.70 |
Description: FBIZ First Business Financial December 28, 2025
First Business Financial Services, Inc. (NASDAQ: FBIZ) is the holding company for First Business Bank, a community-focused lender serving small- and medium-size enterprises, professionals, and high-net-worth individuals across Wisconsin, Kansas, and Missouri. Founded in 1909 and headquartered in Madison, Wisconsin, the bank positions itself as a full-service regional institution.
The bank’s product lineup spans commercial real-estate, industrial, and asset-based lending, as well as specialized financing such as accounts-receivable, equipment, floor-plan, vendor, and SBA loans. Complementary services include treasury management, corporate retirement solutions, and a private-wealth platform that offers asset allocation, trust and estate administration, financial planning, and brokerage custody. Additionally, FBIZ provides balance-sheet consulting, asset-liability management, and standard commercial deposit accounts.
As of the most recent filing, FBIZ reported total assets of roughly $2.2 billion, a loan-to-deposit ratio near 88 %, and a net interest margin of about 3.2 %. The bank’s return on equity hovered around 9 %, reflecting modest profitability in a sector still adjusting to the post-pandemic rate-hike environment. Regional banks like FBIZ are especially sensitive to Federal Reserve policy, which drives net interest income, while small-business loan demand remains linked to U.S. GDP growth and local employment trends.
For a deeper, data-driven valuation framework, you might explore the FBIZ profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 50.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.53 > 1.0 |
| NWC/Revenue: -1329 % < 20% (prev -987.5%; Δ -341.4% < -1%) |
| CFO/TA 0.02 > 3% & CFO 67.5m > Net Income 50.3m |
| Net Debt (227.7m) to EBITDA (47.0m): 4.84 < 3 |
| Current Ratio: 0.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (8.17m) vs 12m ago 0.77% < -2% |
| Gross Margin: 63.84% > 18% (prev 0.55%; Δ 6329 % > 0.5%) |
| Asset Turnover: 6.50% > 50% (prev 6.81%; Δ -0.31% > 0%) |
| Interest Coverage Ratio: 0.40 > 6 (EBITDA TTM 47.0m / Interest Expense TTM 110.6m) |
Altman Z'' -5.12
| A: -0.88 (Total Current Assets 46.7m - Total Current Liabilities 3.33b) / Total Assets 3.76b |
| B: 0.08 (Retained Earnings 294.8m / Total Assets 3.76b) |
| C: 0.01 (EBIT TTM 44.2m / Avg Total Assets 3.80b) |
| D: 0.27 (Book Value of Equity 849.3m / Total Liabilities 3.15b) |
| Altman-Z'' Score: -5.12 = D |
What is the price of FBIZ shares?
Over the past week, the price has changed by +4.41%, over one month by +9.74%, over three months by +17.11% and over the past year by +8.72%.
Is FBIZ a buy, sell or hold?
- StrongBuy: 2
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FBIZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 61.4 | 2.6% |
| Analysts Target Price | 61.4 | 2.6% |
| ValueRay Target Price | 71.7 | 19.8% |
FBIZ Fundamental Data Overview February 01, 2026
P/E Forward = 8.9606
P/S = 3.0193
P/B = 1.3779
P/EG = 1.89
Revenue TTM = 247.3m USD
EBIT TTM = 44.2m USD
EBITDA TTM = 47.0m USD
Long Term Debt = 266.7m USD (from longTermDebt, two quarters ago)
Short Term Debt = 74.8m USD (from shortTermDebt, two quarters ago)
Debt = 274.4m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 227.7m USD (calculated as Total Debt 274.4m - CCE 46.7m)
Enterprise Value = 704.9m USD (477.2m + Debt 274.4m - CCE 46.7m)
Interest Coverage Ratio = 0.40 (Ebit TTM 44.2m / Interest Expense TTM 110.6m)
EV/FCF = 10.53x (Enterprise Value 704.9m / FCF TTM 66.9m)
FCF Yield = 9.49% (FCF TTM 66.9m / Enterprise Value 704.9m)
FCF Margin = 27.06% (FCF TTM 66.9m / Revenue TTM 247.3m)
Net Margin = 20.35% (Net Income TTM 50.3m / Revenue TTM 247.3m)
Gross Margin = 63.84% ((Revenue TTM 247.3m - Cost of Revenue TTM 89.4m) / Revenue TTM)
Gross Margin QoQ = none% (prev 58.71%)
Tobins Q-Ratio = 0.19 (Enterprise Value 704.9m / Total Assets 3.76b)
Interest Expense / Debt = 10.20% (Interest Expense 28.0m / Debt 274.4m)
Taxrate = 17.89% (2.90m / 16.2m)
NOPAT = 36.3m (EBIT 44.2m * (1 - 17.89%))
Current Ratio = 0.01 (Total Current Assets 46.7m / Total Current Liabilities 3.33b)
Debt / Equity = 0.32 (Debt 274.4m / totalStockholderEquity, last quarter 849.3m)
Debt / EBITDA = 4.84 (Net Debt 227.7m / EBITDA 47.0m)
Debt / FCF = 3.40 (Net Debt 227.7m / FCF TTM 66.9m)
Total Stockholder Equity = 472.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.32% (Net Income 50.3m / Total Assets 3.76b)
RoE = 10.66% (Net Income TTM 50.3m / Total Stockholder Equity 472.1m)
RoCE = 5.98% (EBIT 44.2m / Capital Employed (Equity 472.1m + L.T.Debt 266.7m))
RoIC = 5.94% (NOPAT 36.3m / Invested Capital 610.9m)
WACC = 8.58% (E(477.2m)/V(751.6m) * Re(8.70%) + D(274.4m)/V(751.6m) * Rd(10.20%) * (1-Tc(0.18)))
Discount Rate = 8.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.39%
[DCF Debug] Terminal Value 79.16% ; FCFF base≈59.5m ; Y1≈72.3m ; Y5≈118.8m
Fair Price DCF = 188.9 (EV 1.80b - Net Debt 227.7m = Equity 1.57b / Shares 8.33m; r=8.58% [WACC]; 5y FCF grow 22.94% → 2.90% )
EPS Correlation: 68.27 | EPS CAGR: 12.38% | SUE: 1.08 | # QB: 2
Revenue Correlation: 65.27 | Revenue CAGR: 5.23% | SUE: 1.76 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.46 | Chg30d=+0.092 | Revisions Net=-2 | Analysts=2
EPS current Year (2026-12-31): EPS=6.18 | Chg30d=+0.198 | Revisions Net=+0 | Growth EPS=+4.0% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=6.65 | Chg30d=+0.025 | Revisions Net=+0 | Growth EPS=+7.6% | Growth Revenue=+8.6%